In T2D, AMPK and SIRT1 signaling is inhibited, whereas metformin and SGLT-2 inhibitors can activate both signals to facilitate autophagy, respectively (Packer, 2020). This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.